ES2115022T3 - Inmunoensayo de isotiazolonas. - Google Patents

Inmunoensayo de isotiazolonas.

Info

Publication number
ES2115022T3
ES2115022T3 ES93307558T ES93307558T ES2115022T3 ES 2115022 T3 ES2115022 T3 ES 2115022T3 ES 93307558 T ES93307558 T ES 93307558T ES 93307558 T ES93307558 T ES 93307558T ES 2115022 T3 ES2115022 T3 ES 2115022T3
Authority
ES
Spain
Prior art keywords
isotiazolones
immuno assay
monoclonal antibodies
antibodies
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93307558T
Other languages
English (en)
Spanish (es)
Inventor
Gary Lewis Willingham
Chun-Hsien Huang
Richard Farrel Schuman
John Steven Chapman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Application granted granted Critical
Publication of ES2115022T3 publication Critical patent/ES2115022T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/141111—Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES93307558T 1992-09-28 1993-09-23 Inmunoensayo de isotiazolonas. Expired - Lifetime ES2115022T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92776592A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
ES2115022T3 true ES2115022T3 (es) 1998-06-16

Family

ID=25455220

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93307558T Expired - Lifetime ES2115022T3 (es) 1992-09-28 1993-09-23 Inmunoensayo de isotiazolonas.

Country Status (19)

Country Link
US (1) US5554542A (enExample)
EP (1) EP0592127B1 (enExample)
JP (1) JPH07294522A (enExample)
KR (1) KR940006604A (enExample)
CN (1) CN1090929A (enExample)
AT (1) ATE165009T1 (enExample)
AU (1) AU675802B2 (enExample)
BR (1) BR9303898A (enExample)
CA (1) CA2106693A1 (enExample)
CZ (1) CZ202693A3 (enExample)
DE (1) DE69317976T2 (enExample)
DK (1) DK0592127T3 (enExample)
ES (1) ES2115022T3 (enExample)
HU (1) HU214700B (enExample)
IL (1) IL107055A0 (enExample)
MY (1) MY109450A (enExample)
SG (1) SG81877A1 (enExample)
TW (1) TW258789B (enExample)
ZA (1) ZA937028B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218181B1 (en) 1998-03-18 2001-04-17 The Salk Institute For Biological Studies Retroviral packaging cell line
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
NZ532151A (en) * 2004-04-06 2007-09-28 George William Mason John Brod A method of quantitation of chemical preservatives within wood using enzyme linked immunosorbent assay technology combined with chromatographic analysis
WO2007001192A1 (en) * 2005-06-28 2007-01-04 Matthews, John, Brodie Method of determining biocides within wood
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
RU2442793C2 (ru) 2005-11-30 2012-02-20 Эбботт Лэборетриз АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US8912003B2 (en) 2011-08-26 2014-12-16 General Electric Company Methods and devices for detecting isothiazolones
CN113453724B (zh) * 2018-09-27 2025-02-25 皮埃尔法布雷医药公司 基于磺酰基马来酰亚胺的连接子和相应的偶联物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456691A (en) * 1983-02-28 1984-06-26 Suad Stark Antigen for PCB, antibody raised by same, and method of making same
US4652530A (en) * 1985-07-15 1987-03-24 Rohm And Haas Company Monitoring method for isothiazolones in aqueous systems
US4865972A (en) * 1986-08-22 1989-09-12 Westinghouse Electric Corp. Antibody-based bioassay for enzyme-inducing chemicals
IL83419A0 (en) * 1986-09-15 1988-01-31 Westinghouse Electric Corp Antibodies reactive with chlorinated phenols,their preparation and their use
GB9017880D0 (en) * 1990-08-15 1990-09-26 Cambridge Innovation Brokers Assay
US5094957A (en) * 1990-12-10 1992-03-10 Rohm And Haas Company Quantitative method for determining concentration of 3-isothiazolone

Also Published As

Publication number Publication date
CN1090929A (zh) 1994-08-17
HUT67054A (en) 1995-01-30
HU214700B (hu) 1998-08-28
DK0592127T3 (da) 1999-01-04
AU4752493A (en) 1994-04-14
JPH07294522A (ja) 1995-11-10
US5554542A (en) 1996-09-10
ZA937028B (en) 1994-03-29
ATE165009T1 (de) 1998-05-15
HU9302736D0 (en) 1994-01-28
CA2106693A1 (en) 1994-03-29
AU675802B2 (en) 1997-02-20
CZ202693A3 (en) 1994-04-13
KR940006604A (ko) 1994-04-25
EP0592127B1 (en) 1998-04-15
EP0592127A1 (en) 1994-04-13
DE69317976T2 (de) 1998-11-12
IL107055A0 (en) 1993-12-28
TW258789B (enExample) 1995-10-01
SG81877A1 (en) 2001-07-24
BR9303898A (pt) 1994-06-14
DE69317976D1 (de) 1998-05-20
MY109450A (en) 1997-01-31

Similar Documents

Publication Publication Date Title
ES2168376T3 (es) Anticuerpos que activan un receptor de eritropoyetina.
ES2114487B1 (es) Mezcla estabilizante sinergistica.
SE9404250D0 (sv) Affinity separation method
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
MX9203607A (es) Anticuerpo monoclonal que define un antigeno glicolipido asociado con carcinomas pulmonares en humanos, de celulas no pequeñas.
AU691995B2 (en) Interference-suppressing reagent specific to certain classes of antibodies
MX9302461A (es) Benzo-y piridopiridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ES2079386T3 (es) Ensayos para beta-lactamasa que utilizan los sustratos capaces de precipitar un cromogeno.
DE60017019D1 (de) Antikörper gegen Spaltprodukte von Vimentin
CO4520312A1 (es) Un metodo de interconexion
ES2123597T3 (es) Construcciones de anticuerpos que se unen a granulocitos, su preparacion y empleo.
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
ATE109834T1 (de) Monoklonaler antikörper spezifisch gegen humane pankreas-phospholipase-a2.
NO890116D0 (no) Monoklonale antistoffer.
ES508285A0 (es) Un procedimiento para la determinacion cuantitativa y cualitativa de antigenos, anticuerpos y complejos de los mismos.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
EA199700449A1 (ru) Способ предотвращения остеопороза
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
DE69023717D1 (de) Monoklonaler Antikörper.
EP0175928A3 (en) Image understanding system
EA200000705A1 (ru) Промежуточные соединения и способ синтеза 17-замещенных 16.бета.-арилокси 4-азастероидов
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 592127

Country of ref document: ES